Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polyclonal antibodies and catalysis

D B Stephens1, B H Wilmore, B L Iverson

  • 1Department of Chemistry and Biochemistry, University of Texas at Austin 78712.

Bioorganic & Medicinal Chemistry
|July 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploiting the interactions of aromatic units for folding and assembly in aqueous environments.

Chemical communications (Cambridge, England)·2016
Same author

Detection of anthrax toxin in the serum of animals infected with Bacillus anthracis by using engineered immunoassays.

Clinical and vaccine immunology : CVI·2006
Same author

Passive protection against anthrax by using a high-affinity antitoxin antibody fragment lacking an Fc region.

Infection and immunity·2005
Same author

Models of higher-order structure: foldamers and beyond.

Current opinion in chemical biology·2001
Same author

Production of correctly folded Fab antibody fragment in the cytoplasm of Escherichia coli trxB gor mutants via the coexpression of molecular chaperones.

Protein expression and purification·2001
Same author

The synthesis and screening of 1,4,5,8-naphthalenetetracarboxylic diimide-peptide conjugates with antibacterial activity.

Bioorganic & medicinal chemistry·2001
Same journal

Recent advances in Camptothecin-derived antibody-drug conjugates.

Bioorganic & medicinal chemistry·2026
Same journal

CDK4/6-targeted therapy: From clinical inhibitors to emerging strategies to overcome resistance.

Bioorganic & medicinal chemistry·2026
Same journal

Coumarin-sulfonamide hybrids as PKM2 activators induce metabolic reprogramming and suppress ovarian cancer cell growth.

Bioorganic & medicinal chemistry·2026
Same journal

Recent advances in the development of small-molecule drugs based on covalent reversible inhibitors.

Bioorganic & medicinal chemistry·2026
Same journal

Computational hybrid approach of PBPK simulation and CGCNN models for human intravenous pharmacokinetics.

Bioorganic & medicinal chemistry·2026
Same journal

Assessing the use of foundation model embeddings to improve drug response predictions using scRNA-Seq expression data.

Bioorganic & medicinal chemistry·2026
See all related articles

Catalytic polyclonal antibodies offer insights into overall immune response to haptens. Studying these antibodies aids in understanding catalytic activity trends and developing new therapies.

Area of Science:

  • Immunology
  • Biochemistry
  • Catalysis

Background:

  • Polyclonal antibodies are a diverse mixture of immunoglobulins.
  • Catalytic antibodies possess enzymatic activity.
  • Understanding antibody catalysis is crucial for immunology and therapeutics.

Purpose of the Study:

  • To describe recent findings on catalytic polyclonal antibodies.
  • To highlight the utility of polyclonal antibodies in characterizing catalytic activity.
  • To explore applications in understanding immune responses and developing therapies.

Main Methods:

  • Isolation of polyclonal antibodies directly from serum.
  • Characterization of catalytic activity within the antibody distribution.
  • Analysis of IgG antibodies elicited via immunization.

Related Experiment Videos

Main Results:

  • Polyclonal antibodies reflect the complete distribution of elicited IgG antibodies.
  • Catalytic results from polyclonal antibodies characterize overall immune response to a hapten.
  • Demonstrated utility in identifying structure-activity relationships and monitoring catalytic maturation.

Conclusions:

  • Polyclonal antibodies provide a comprehensive view of catalytic antibody activity.
  • This approach aids in studying catalytic activity variability and maturation.
  • Potential applications exist for novel immunization-based therapies.